UniSa - IRIS Institutional Research Information System

SELLERI, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.250
EU - Europa 5.288
AS - Asia 3.891
SA - Sud America 524
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 13
Totale 27.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.173
SG - Singapore 1.283
CN - Cina 1.237
UA - Ucraina 1.189
IT - Italia 1.055
DE - Germania 919
RU - Federazione Russa 734
BR - Brasile 478
FI - Finlandia 478
IE - Irlanda 428
VN - Vietnam 422
KR - Corea 295
TR - Turchia 267
HK - Hong Kong 187
SE - Svezia 171
AT - Austria 101
IN - India 76
GB - Regno Unito 62
CA - Canada 53
CZ - Repubblica Ceca 42
JP - Giappone 35
EU - Europa 28
ET - Etiopia 23
NL - Olanda 22
PL - Polonia 19
ES - Italia 16
AR - Argentina 15
BD - Bangladesh 15
FR - Francia 13
MX - Messico 11
PK - Pakistan 10
UZ - Uzbekistan 10
AU - Australia 9
VE - Venezuela 9
EC - Ecuador 8
ID - Indonesia 8
ZA - Sudafrica 8
EG - Egitto 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
IQ - Iraq 6
JO - Giordania 6
KE - Kenya 5
PS - Palestinian Territory 5
CL - Cile 4
HN - Honduras 4
HU - Ungheria 4
LU - Lussemburgo 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PE - Perù 4
BE - Belgio 3
IL - Israele 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
MY - Malesia 3
RS - Serbia 3
BG - Bulgaria 2
BO - Bolivia 2
BZ - Belize 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
IR - Iran 2
LK - Sri Lanka 2
LT - Lituania 2
LY - Libia 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
KZ - Kazakistan 1
MD - Moldavia 1
NG - Nigeria 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 27.050
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.703
Woodbridge 2.446
Jacksonville 1.460
Chandler 1.347
Princeton 1.164
Houston 1.162
Wilmington 1.110
Ashburn 494
Singapore 458
Dong Ket 422
Dublin 406
Munich 390
Andover 283
Nanjing 258
Boardman 245
Izmir 245
Beijing 240
Moscow 216
Salerno 208
Hong Kong 178
Pellezzano 171
Helsinki 150
Düsseldorf 145
Naples 129
Fairfield 100
Shenyang 90
Nanchang 86
Changsha 84
Nuremberg 81
Jiaxing 80
Hebei 77
Los Angeles 74
Turku 60
Dallas 55
Redwood City 55
Washington 54
Norwalk 48
Tianjin 46
Rome 44
Vienna 44
Pune 39
Dearborn 37
São Paulo 37
Brno 36
Napoli 36
New York 35
Cambridge 34
Seattle 33
The Dalles 28
San Diego 27
Addis Ababa 23
Brooklyn 23
Milan 23
Santa Clara 23
Guangzhou 22
Rio de Janeiro 22
Jinan 21
Mestre 20
San Francisco 20
Belo Horizonte 19
Falls Church 18
Grevenbroich 17
Jyväskylä 17
Tokyo 17
Warsaw 17
Fisciano 16
London 15
Ottawa 15
Chicago 14
Lappeenranta 14
Phoenix 13
Toronto 13
Zhengzhou 13
Boston 12
Charlotte 12
Shanghai 12
Tappahannock 11
Brasília 10
Caserta 10
Columbus 10
Hillsboro 10
Tashkent 10
Amsterdam 9
Manchester 9
Stockholm 9
Cava de' Tirreni 8
Contagem 8
Hefei 8
Indiana 8
Pisa 8
Atlanta 7
Council Bluffs 7
Curitiba 7
Haikou 7
Mumbai 7
Palermo 7
Richmond 7
Teano 7
West Jordan 7
Amman 6
Totale 20.098
Salva come PNG Salva come JPEG
Nome #
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 255
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 171
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 171
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 139
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 137
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 136
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 135
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 135
Bendamustine in combination with rituximab as first line therapy for patients with chronic lymphocytic leukemia (cll): a retrospective real practice italian multicentre study. 133
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 130
A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. 127
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 126
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes 124
Continuous alternate-day low dose lenalidomide in combination with low dose prednisone as frontline treatment for octogenarian newly diagnosed multiple myeloma patients 124
High dose rHuEPO may induce complete remission in AML-M6 123
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 121
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 121
High frequency of extramedullary relapse in patients transplanted for acute myeloid leukemia. 118
Impact of cytokine gene polymorphisms in myelodysplastic syndromes (MDS) 116
Allogeneic transplantation for multiple myeloma 116
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. 115
Higher expression of Fas receptor on CD34+ cells of chronic myelogenous leukemia correlates with hematological response to IFN-alfa. 115
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 115
Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients 114
67 kDa laminin receptor: structure, function and role in cancer and infection. 114
Adjuvant treatment of diabetic foot 114
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 114
A GITMO randomised trial in steroid refractory acute graft-versus-host disease: 6methylprednisolone with or without anti-thymocyte globulin 113
Two year follow-up of cyclosporin-A in hypoplastic myelodysplastic leukemia. 113
IgH assessment of non-Hodgkin lymphoma cells on FTA cards. 113
Fas-mediated downmodulation of p210 BCR/ABL results in apoptosis of CD34+ cells of chronic myelogenous leukemia. 112
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 111
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 110
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 110
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 109
A backwards evolution in a case of myeloproliferative disease 109
The urokinase-receptor in infectious diseases. 109
Effects of leptin and IGF-1 on bone mineral density in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 108
Increased expression of the signaling lymphocyte-activation molecule (mSLAM) in patients with paroxysmal nocturnal hemoglobinuria (PNH). 108
Impact of cytokine gene polymorphism in aplastic anemia (AA) 108
Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study 108
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 107
A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. 107
Long-term follow-up of a pilot study with alemtuzumab and low-dose cyclosporine a for aplastic anaemia and single-lineage marrow failures. 107
Blockade of intravascular hemolysis in PNH with the terminal complement inhibitor eculizumab unmasks low-level hemolysis potentially occurring through C3 opsonization 107
Subcutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: a pilot study from the working party aplastic anaemia (WPSAA) 107
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 107
Ultrasound image of pleural granulocytic sarcoma. 106
Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond. 106
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey 106
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 106
Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. 105
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 105
FAS antigen expression on normal and aplastic CD34+ cells. 105
Imatinib as salvage therapy for patients with refractory cGVHD 105
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 105
Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. 104
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 104
Fas-Ligand expressed on acute leukemia cells may kill Fas positive Jurkat cells. 103
Estrogen-progestin-replacement therapy in women after stem cell transplant 102
Inhibition of interferon regulatory factor-1 expression induces interferon-gamma to stimulate CD34+ cells. 102
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 102
Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. 101
Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies. 101
Previous occurrence of life-threatening abdominal infection is not a contraindication to marrow transplant. 101
Farnesyltransferase inhibition may revert in vitro Fas-mediated apoptosis of clonogenic chronic myeloid leukemia cells. 101
Nitric oxide and cell survival: megakaryocytes say "NO". 100
Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy. 100
Bone marrow long-term initiating cells are decreased after allogeneic bone marrow transplantation. 100
Cyclosporin-A may improve in vitro circulating hematopoietic progenitors growth and affects CD4 cells expressing interferon-gamma of hypoplastic myelodysplastic patients. 100
Bendamustine in combination with rituximab for elderly patients with aggressive B non hodgkin lymphoma not eligible for anthracycline-based therapy 100
Fine needle aspiration cytology of lymphoproliferative lesions of the oral cavity 100
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 99
The pathophysiology of aquired aplastic anemia. 99
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 99
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 99
Circulating T regulatory cells (TREG) are decreased in patients with aplastic anemia (AA). 98
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 98
EFFICACY OF ALEMTUZUMAB PLUS EXTRACORPOREAL PHOTOPHERESIS IN ADVANCED STAGE SEZARY SYNDROME: A CASE REPORT 98
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 98
Role of the urokinase receptor in hematopoietic stem cell transplantation 97
Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GvHD. 97
Avascular necrosis after allogeneic hematopoietic stem cell transplantation: An observational study on the effects of zoledronic acid 97
Imatinib in 34 patients with steroid-refractory chronic graft-versus-host-disease: final evaluation of the second prospective trial, according to the NIH Consensus criteria for cGvHD 97
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 97
Fanconi's anemia cells are relatively resistant to H2O2-induced damage. 96
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 96
Interferon-alpha may modulate the balance between FAS-receptor and FAS-ligand expression on bone marrow chronic myeloid leukemia cells. 96
Subcutaneous Alemtuzumab Is a safe and effective treatment for global or single lineage immune-mediated marrow failures: a survey from the EBMT-WPSAA. 96
Increased expression of Fas-ligand on bone marrow progenitor cells of patients with chronic myeloid leukemia. 96
Interferon regulatory factor-1 partially mediates interferon-gamma hematopoietic inhibition. 96
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 96
Prognostic irrelevance of CD34 in acute myeloid leukaemia. 95
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. 95
Immunosuppression by alemtuzumab for the treatment of bone marrow failure of bone marrow failure syndromes 95
Management of paroxysmal nocturnal haemoglobinuria in the eculizumab era: the bedside and beyond 95
Imbalance of the osteprotegerin/RANKL system in bone marrow microenvironment after allogeneic transplant of hemopoietic stem cell 95
Fine-needle cytology in the follow-up of breast carcinoma 95
Acute promyelocytic leukemia following myelodysplasia and Fanconi-like syndrome 95
Cryptozoospermia with normal testicular function after allogeneic stem cell transplantation: a case report. 94
Totale 11.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.182
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.335 28 242 248 11 328 74 266 25 247 36 357 473
2021/20222.072 21 9 15 65 58 61 21 74 309 273 267 899
2022/20233.454 333 179 103 358 477 728 52 354 560 22 176 112
2023/20241.769 182 250 131 101 144 264 75 93 16 68 105 340
2024/20254.744 165 77 63 149 223 610 880 501 672 253 500 651
2025/202652 52 0 0 0 0 0 0 0 0 0 0 0
Totale 27.732